ONS-01 is a mission-critical performance system engineered for U.S. military and allied force deployment.

It is engineered to solve the specific challenges of modern combat feeding: logistics friction, thermal degradation, and the physiological attrition of the Warfighter.

• Clinical vs. Commercial: Developed over 3 years by doctors, not marketers.
• Zero Footprint: 100% biodegradable/burnable; leaves no trace in theater.
• Total Stability: 24-month shelf life with zero refrigeration; storage-stable in extreme desert heat.
• Ready for GSA: Categorized under GSA SIN 311423 (Non-Perishable Foods). Regulatory documentation available upon request in accordance with applicable federal guidelines.

Minimum Order Quantity (MOQ):

1 Metric TonTo maintain fixed GSA pricing and ensure total supply chain integrity, ONS-01 is supplied in 1-metric-ton increments. This ensures that forces receive thecumulative dosagerequired for clinical-grade physiological protection. The "Power of One Ton" (The 312-Soldier Metric)One metric ton is a specialized, high-density unit of readiness designed for unit-level deployment:

• Total Content: 28,090 individual 35.6g sachets.
• Daily Rations: 9,363 full 3-sachet daily protocols.
• Sustained Support: One metric ton supports 312 personnel for 30 days.
• Unit Cost (Delivered): $223,000 per Metric Ton.
• Daily Cost Per Soldier: $23.82 (Includes 3 sachets per day).

The Mission Logic

• Combat Readiness vs. Trial Orders: Small-scale, "trial-sized" orders (e.g., 5,000 sachets) are logistically inefficient and fail to provide the sustained physiological loading necessary for force-wide readiness.
• GSA Price Protection: Procurement in 1-metric-ton units aligns with GSA pricing structures and supports structured production scheduling within our high-capacity manufacturing facilities.

The Military’s Most Expensive Problem: Musculoskeletal Injuries (MSKI)

While the daily cost of ONS-01 is fixed at GSA rates, the cost of inaction is volatile and extreme. Musculoskeletal injuries are the leading cause of medical evacuation, non-deployability, and early discharge across all U.S. Military branches.

The Financial Reality of the DoD:

• The Annual Burden: MSKIs cost the U.S. Department of Defense over $3.7 Billion annually in direct medical costs and lost productivity.
• The Individual Event: A single combat or training-related injury (tears, fractures, or chronic degradation) estimated to cost the DoD tens of thousands of dollars per incident in surgery, evacuation, and recovery.
• The Readiness Gap: "Limited Duty" days represent a hidden cost of over $4 Billion to the Army alone, as soldiers remain on payroll but cannot fulfill mission requirements.

The ONS-01 "Insurance" Factor:

By integrating ONS-01 as a mandatory daily readiness protocol, the DoD effectively "insures" its most valuable asset: the Warfighter.

• Break-Even Analysis: If the ONS-01 protocol prevents just one $50,000 medical event within a 312-soldier unit, the entire cost of the metric ton is effectively neutralized.
• Force Preservation: ONS-01 targets the specific root causes of non-combat attrition — connective tissue failure and central nervous system fatigue — where standard MREs and civilian proteins fail.

Conclusion

You are not procuring "powder"; you are procuring Personnel Availability and Long-term Budgetary Savings.

Current Operational Capacity

ONS-01 is currently in active, validated production.

Blackstone Group’s existing European manufacturing facility currently operates at:

260 metric tons per month of production capacity

This represents immediate readiness to support:

• National-level force deployment
  
• NATO-scale procurement volumes
  
• Multi-branch sustained operational programs
  

Production is active, validated, and scalable without dependency on new facility construction for initial contracts.

ONS-01 is deliverable at scale from day one.

Current monthly production capacity of 260 metric tons is operational and contract-allocatable for U.S. government requirements.

Operational Production Record

ONS-01 manufacturing processes have been operationally validated through multi-year production cycles under industrial-scale quality control systems. Full batch traceability, stability testing, and compliance documentation are maintained and available to authorized procurement officers upon request.

Blackstone Group has formally communicated its commitment to strengthening the U.S. Defense Industrial Base through phased domestic manufacturing expansion aligned with long-term Department of Defense procurement agreements.

Structured Expansion Model

• Multi-site U.S.-based production facilities
  
• Designed for national and allied force-level demand
  
• Activation directly proportional to awarded contract scale
  
• Self-funded industrial infrastructure aligned with federal procurement stability
  

Expansion is structured to scale alongside multi-year defense contracts — not ahead of them.

This ensures:

• Controlled capital deployment
  
• Supply chain continuity
  
• Contract-aligned growth
  
• Zero speculative overbuild

Future U.S. facilities will prioritize the recruitment of U.S. military veterans across operational, supervisory, and technical roles.

This initiative is designed to:

• Integrate mission-aligned operational experience into production environments
  
• Strengthen cultural alignment with defense objectives
  
• Support long-term workforce stability within the defense manufacturing sector
  

Each U.S. facility is projected to generate:

1,500 – 2,000 high-skill American jobs

Workforce development will align with federal labor and defense industrial workforce initiatives.

Veteran workforce integration reduces onboarding friction for mission-specific production environments.

Current production is located in France within a NATO-aligned industrial framework.

The long-term roadmap transitions production toward:

100% U.S.-based sovereign manufacturing

This transition is designed to ensure:

• Domestic supply chain security
  
• Elimination of cross-border logistics risk
  
• Strategic autonomy for U.S. defense programs
  
• Long-term production resilience
  

The transition timeline is contract-aligned and structured for continuity of supply.

Production is supported by multi-line manufacturing redundancy and raw material sourcing diversification to ensure uninterrupted supply under geopolitical disruption scenarios.

Current production capacity supports high-volume, sustained deployment cycles.

The manufacturing structure is capable of:

• Rapid volume escalation under surge conditions
  
• Strategic reserve replenishment programs
  
• NATO-aligned multi-theater support
  

Capacity signaling is based on operational infrastructure, not projections.

ONS-01SF is a gel-based, ready-to-consume adaptation of the ONS-01 system engineered for environments where liquid mixing is impractical.

Designed for:

• Microgravity operations
  
• Aerospace deployment environments
  
• Extended-duration missions
  

ONS-01SF addresses accelerated musculoskeletal degradation observed in prolonged microgravity exposure.

Positioning remains capability-specific and independent from ground-force procurement structures.

• GSA Schedule: MAS (SIN 311423)
• Contractor: Blackstone Group LLC-FZ
• Strategic Contact: Mario M. Radosavljevic, Executive Director
• Email: contact@blackstonegroupdubai.com
• Letters of Intent (LOI) regarding U.S. factory construction are available for review by authorized DoD/Congressional officials.